drugset / Trial / NCT03878589
Understanding Cognition, Oxytocin & Pain in Elders
RandomizedCrossoverQuadruple-blindTreatment
Summary
Osteoarthritis (OA) represents a significant cause of disability worldwide and the knee is the most commonly affected joint. Oxytocin (OT) is a mediator of endogenous analgesia in animal and human studies. This proposal will test the efficacy and safety of self-administered intranasal OT over 4-weeks in older individuals relative to placebo (P) evaluating its effects on pain and function in aging and testing potential underlying neurobiological mechanisms.
Timeline
- Start
- 2019-08-06
- Primary completion
- 2024-12-19
- Completion
- 2024-12-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Oxytocin | Peptide | 24 iu | Intranasal |